Načítá se...
Etanercept in the treatment of SAPHO syndrome: Which place?
Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome (SAPHO) is a rare disease combining skin, bone, and joint manifestations. Its treatment remains a debated issue in the absence of a valid therapeutic strategy. The experience with tumor necrosis factor alpha (TNF alpha)-blocking agents...
Uloženo v:
| Vydáno v: | Eur J Rheumatol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medical Research and Education Association
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5042223/ https://ncbi.nlm.nih.gov/pubmed/27708894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheumatol.2014.037 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|